We are live on ! Find out more
LEGN icon

Legend Biotech
LEGN

206 hedge funds and large institutions have $5.22B invested in Legend Biotech in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 93 increasing their positions, 58 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

201% more call options, than puts

Call options by funds: $58.4M | Put options by funds: $19.4M

60% more repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 58

26% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 27

3% more funds holding

Funds holding: 200 → 206 (+6)

0.22% more ownership

Funds ownership: 26.05% → 26.27% (+0.22%)

10% less capital invested

Capital invested by funds: $5.78B → $5.22B (-$559M)

13% less funds holding in top 10

Funds holding in top 10: 8 → 7 (-1)

Holders
206
Holders Change
+6
Holders Change %
+3%
% of All Funds
3%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.1%
New
34
Increased
93
Reduced
58
Closed
27
Calls
$58.4M
Puts
$19.4M
Net Calls
+$39M
Net Calls Change
+$40.4M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$70.6M
2
Morgan Stanley
Morgan Stanley
New York
+$62.3M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$61M
4
BlackRock
BlackRock
New York
+$40.9M
5
Millennium Management
Millennium Management
New York
+$35.3M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$197M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$69.3M
3
NIP
Nicholas Investment Partners
California
-$35.9M
4
PCH
Polar Capital Holdings
United Kingdom
-$31.8M
5
HA
HHLR Advisors
Cayman Islands
-$28.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
PP
126
Prudential plc
United Kingdom
$894K +$377K +5,949 +67%
Teacher Retirement System of Texas
127
Teacher Retirement System of Texas
Texas
$879K +$174K +2,752 +23%
Voloridge Investment Management
128
Voloridge Investment Management
Florida
$878K -$8.1M -127,843 -90%
Two Sigma Advisers
129
Two Sigma Advisers
New York
$866K -$5.46M -86,100 -86%
Vontobel Holding
130
Vontobel Holding
Switzerland
$789K +$831K +13,117 New
PCM
131
Prelude Capital Management
New York
$783K +$170K +2,687 +26%
PL
132
Parkwood LLC
Ohio
$775K -$43.3K -683 -5%
Mitsubishi UFJ Trust & Banking
133
Mitsubishi UFJ Trust & Banking
Japan
$761K +$21K +331 +3%
PM
134
Parametrica Management
Hong Kong
$710K +$748K +11,800 New
VA
135
Vident Advisory
Georgia
$706K -$33.8K -534 -4%
Skandinaviska Enskilda Banken (SEB)
136
Skandinaviska Enskilda Banken (SEB)
Sweden
$657K +$203K +3,200 +42%
BCM
137
Bayesian Capital Management
New York
$656K +$691K +10,906 New
DekaBank Deutsche Girozentrale
138
DekaBank Deutsche Girozentrale
Germany
$589K -$87.1K -1,374 -12%
OCBCO
139
Oversea-Chinese Banking Corp (OCBC)
Singapore
$560K +$131K +2,069 +29%
CUAMC
140
China Universal Asset Management Company
China
$555K +$455K +7,174 +350%
Asset Management One
141
Asset Management One
Japan
$542K +$33.3K +526 +6%
AP
142
AtonRa Partners
Switzerland
$532K -$67.5K -1,065 -11%
NSEDCP
143
NJ State Employees Deferred Compensation Plan
New Jersey
$499K – – –
Wells Fargo
144
Wells Fargo
California
$493K +$128K +2,022 +33%
Ensign Peak Advisors
145
Ensign Peak Advisors
Utah
$472K – – –
AWM
146
Avior Wealth Management
Nebraska
$445K +$11.5K +182 +3%
WC
147
Wexford Capital
Florida
$425K -$447K -7,061 -50%
Macquarie Group
148
Macquarie Group
Australia
$414K +$81.3K +1,283 +23%
HI
149
Handelsinvest Investeringsforvaltning
Denmark
$404K +$425K +6,707 New
EOJOAM
150
E. Ohman J:or Asset Management
Sweden
$397K -$108K -1,700 -20%
4 5
6
7 8

LEGN Hedge Fund Activity: Q4 2023 in Review

206 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Legend Biotech (LEGN) for Q4 2023, worth a combined $5.22B — down 9.7% from $5.78B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new LEGN positions and 27 closed out — a net gain of 7 holders — while 93 added to existing stakes and 58 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $70.6M. The largest seller was Fidelity Investments, cutting an estimated $197M.

  • 206 institutional investors held Legend Biotech (LEGN) as of Q4 2023, up from 200 in Q3 2023.
  • Funds reported $5.22B of Legend Biotech stock for Q4 2023, down 9.7% quarter-over-quarter.
  • 34 funds opened new Legend Biotech positions in Q4 2023 and 27 closed out, a net change of +7 holders.
  • The largest Legend Biotech buyer in Q4 2023 was T. Rowe Price Associates, an estimated $70.6M added.
  • The largest Legend Biotech seller in Q4 2023 was Fidelity Investments, an estimated $197M sold.

Based on aggregated 13F filings for Q4 2023.